Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery

Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery

The evolution of respiratory diseases represents a considerable public health challenge, as they are among the leading causes of death worldwide. In this sense, in addition to the high prevalence of diseases such as asthma, chronic obstructive pulmonary disease, pneumonia, cystic fibrosis, and lung...

Full description

Bibliographic Details
Main Authors: Thiago Medeiros Zacaron, Mariana Leite Simões e Silva, Mirsiane Pascoal Costa, Dominique Mesquita e Silva, Allana Carvalho Silva, Ana Carolina Morais Apolônio, Rodrigo Luiz Fabri, Frederico Pittella, Helvécio Vinícius Antunes Rocha, Guilherme Diniz Tavares
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Polymers
Subjects:
lung diseases
pulmonary drug delivery
lung delivery
chitosan
chitosan derivatives
nanoparticles
Online Access:https://www.mdpi.com/2073-4360/15/18/3849

Internet

https://www.mdpi.com/2073-4360/15/18/3849

Similar Items